PUBLISHER: Global Market Insights Inc. | PRODUCT CODE: 2019196
PUBLISHER: Global Market Insights Inc. | PRODUCT CODE: 2019196
Iliac Stents Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2026 - 2035
The Global Iliac Stents Market was valued at USD 1 billion in 2025 and is estimated to grow at a CAGR of 4.7% to reach USD 1.6 billion by 2035.
Market expansion is driven by growing preference for minimally invasive procedures, advancements in stent materials and designs, and the increasing prevalence of peripheral artery disease (PAD). As populations age and risk factors such as diabetes, obesity, and smoking become more common, the incidence of PAD continues to climb, resulting in leg pain, cramping, and walking difficulties that affect quality of life. Clinical evidence demonstrating the long-term efficacy of stents, coupled with their expanding use in complex iliac lesions, is further fueling demand. The shift toward personalized vascular treatments has also amplified the adoption of iliac stents. These small, mesh-like devices, typically made from stainless steel or nitinol, are inserted into narrowed arteries to restore proper blood flow, improving patient outcomes while minimizing procedural risks compared to traditional open surgeries.
| Market Scope | |
|---|---|
| Start Year | 2025 |
| Forecast Year | 2026-2035 |
| Start Value | $1 Billion |
| Forecast Value | $1.6 Billion |
| CAGR | 4.7% |
The common iliac artery lesions segment reached USD 639.6 million in 2025. Rising global risk factors such as hypertension, diabetes, and obesity accelerate atherosclerosis, increasing the number of patients requiring interventions. Minimally invasive techniques like angioplasty and stenting have revolutionized care for iliac artery lesions, driving adoption and demand.
The hospitals segment held a 56.8% share in 2025. These facilities are equipped with specialized units in interventional cardiology, vascular surgery, and radiology, staffed by skilled professionals capable of performing complex iliac stent procedures. Access to comprehensive resources, including medical supplies, medications, and support staff, positions hospitals as the primary end users for these devices.
U.S. Iliac Stents Market was valued at USD 225.2 million in 2025. Rising diabetes and obesity rates, coupled with increased R&D investments, are key growth drivers. Greater awareness among patients and healthcare providers has improved early diagnosis and intervention, while strong clinical evidence and guideline-backed recommendations for endovascular treatments reinforce the demand for iliac stents in the region.
Key players operating in the Global Iliac Stents Market include Medtronic, Boston Scientific, Abbott Laboratories, Biotronik, Becton, Dickinson and Company, Alvimedica, W. L. Gore & Associates, Inc., Cook, Cordis, iVascular, Getinge, and B. Braun. Companies in the Iliac Stents Market strengthen their position by focusing on research and development to create stents with enhanced flexibility, durability, and biocompatibility. Strategic partnerships with hospitals and healthcare providers expand product reach and adoption. Market penetration is supported by clinical trials that validate efficacy and safety, enhancing physician confidence. Firms also leverage regional expansions, regulatory approvals, and targeted educational programs for clinicians and patients to boost awareness. Additionally, collaborations with medical device distributors and the implementation of customized solutions for complex lesions help consolidate market share and maintain a competitive advantage.
Table of Contents
Chapter 1 Research Methodology
- 1.1 Research approach
- 1.2 Quality commitments
- 1.2.1 GMI AI policy & data integrity commitment
- 1.2.1.1 Source consistency protocol
- 1.2.1 GMI AI policy & data integrity commitment
- 1.3 Research trail & confidence scoring
- 1.3.1 Research trail components
- 1.3.2 Scoring components
- 1.4 Data collection
- 1.4.1 Partial list of primary sources
- 1.5 Data mining sources
- 1.5.1 Paid sources
- 1.5.1.1 Sources, by region
- 1.5.1 Paid sources
- 1.6 Base estimates and calculations
- 1.6.1 Base year calculation
- 1.7 Forecast model
- 1.7.1 Quantified market impact analysis
- 1.7.1.1 Mathematical impact of growth parameters on forecast
- 1.7.1 Quantified market impact analysis
- 1.8 Research transparency addendum
- 1.8.1 Source attribution framework
- 1.8.2 Quality assurance metrics
- 1.8.3 Our commitment to trust
Chapter 2 Executive Summary
- 2.1 Industry 360° synopsis
- 2.2 Key market trends
- 2.2.1 Regional trends
- 2.2.2 Type trends
- 2.2.3 Artery lesions trends
- 2.2.4 End use trends
- 2.3 CXO perspectives: Strategic imperatives
Chapter 3 Industry Insights
- 3.1 Industry ecosystem analysis
- 3.2 Industry impact forces
- 3.2.1 Growth drivers
- 3.2.1.1 Increasing prevalence of peripheral artery disease (PAD)
- 3.2.1.2 Technological advancements in stents design and materials
- 3.2.1.3 Rising demand for minimally invasive procedures
- 3.2.2 Industry pitfalls and challenges
- 3.2.2.1 Stringent regulatory approvals
- 3.2.2.2 High cost of stent procedures and devices
- 3.2.3 Opportunities
- 3.2.3.1 Growing adoption of image-guided endovascular procedures
- 3.2.1 Growth drivers
- 3.3 Growth potential analysis
- 3.4 Regulatory landscape (Driven by Primary Research)
- 3.4.1 North America
- 3.4.2 Europe
- 3.4.3 Asia Pacific
- 3.5 Technology and innovation landscape
- 3.5.1 Current technological trends
- 3.5.2 Emerging technologies
- 3.6 Future market trends (Driven by Primary Research)
- 3.7 Reimbursement scenario
- 3.8 Impact of AI & generative AI on the market (Driven by Primary Research)
- 3.8.1 AI-Driven disruption of existing business models
- 3.8.2 GenAI use cases & adoption roadmap by segment
- 3.9 Price trends, by type, 2025 (Driven by Primary Research)
- 3.10 Gap analysis
- 3.11 Porter's analysis
- 3.12 PESTEL analysis
Chapter 4 Competitive Landscape, 2025
- 4.1 Introduction
- 4.2 Company matrix analysis
- 4.3 Company market share analysis (Driven by Primary Research)
- 4.3.1 Global
- 4.3.2 North America
- 4.3.3 Europe
- 4.3.4 Asia Pacific
- 4.4 Competitive analysis of major market players
- 4.5 Competitive positioning matrix
- 4.6 Key developments
- 4.6.1 Mergers & acquisitions
- 4.6.2 Partnerships & collaborations
- 4.6.3 New product launches
- 4.6.4 Expansion plans
Chapter 5 Market Estimates and Forecast, By Type, 2022 - 2035 ($ Mn)
- 5.1 Key trends
- 5.2 Self-expandable stents
- 5.3 Balloon-expandable stents
- 5.4 Covered stents
Chapter 6 Market Estimates and Forecast, By Artery Lesions, 2022 - 2035 ($ Mn)
- 6.1 Key trends
- 6.2 Common iliac artery lesions
- 6.3 Severe calcified lesions
- 6.4 Complete obstructive lesions
Chapter 7 Market Estimates and Forecast, By End Use, 2022 - 2035 ($ Mn)
- 7.1 Key trends
- 7.2 Hospitals
- 7.3 Ambulatory surgical centers
- 7.4 Other end users
Chapter 8 Market Estimates and Forecast, By Region, 2022 - 2035 ($ Mn)
- 8.1 Key trends
- 8.2 North America
- 8.2.1 U.S.
- 8.2.2 Canada
- 8.3 Europe
- 8.3.1 Germany
- 8.3.2 UK
- 8.3.3 France
- 8.3.4 Spain
- 8.3.5 Italy
- 8.3.6 Netherlands
- 8.4 Asia Pacific
- 8.4.1 China
- 8.4.2 Japan
- 8.4.3 India
- 8.4.4 Australia
- 8.4.5 South Korea
- 8.5 Latin America
- 8.5.1 Brazil
- 8.5.2 Mexico
- 8.5.3 Argentina
- 8.6 MEA
- 8.6.1 South Africa
- 8.6.2 Saudi Arabia
- 8.6.3 UAE
Chapter 9 Company Profiles
- 9.1 Abbott Laboratories
- 9.2 Alvimedica
- 9.3 B. Braun
- 9.4 Becton, Dickinson and Company
- 9.5 Biotronik
- 9.6 Boston Scientific
- 9.7 Cook
- 9.8 Cordis
- 9.9 Getinge
- 9.10 iVascular
- 9.11 Medtronic
- 9.12 W. L. Gore & Associates, Inc.
